Akhilesh Dubey

Dr. Akhilesh Dubey

orcid
Lipid Based Drug Delivery System, Combisomes, Topical, Non-I...

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2020 in AAPS PharmSciTech
Verified
Journal Article
Closed access
PDF file
SVSandhya Vasanth
Sandhya Vasanth
Akhilesh DubeyAkhilesh Dubey
Akhilesh Dubey
RGRavi G.S.
Ravi G.S.
SLShaila A. Lewis
Shaila A. Lewis
VGVivek M. Ghate
Vivek M. Ghate
SHSrinivas Hebbar
Srinivas Hebbar

2 October 2018 in AAPS PharmSciTech
Verified
Journal Article
Closed access
PDF file
GRG. S. Ravi
G. S. Ravi
RCR. Narayana Charyulu
R. Narayana Charyulu
Akhilesh DubeyAkhilesh Dubey
Akhilesh Dubey
PPPrabhakara Prabhu
Prabhakara Prabhu
SHSrinivas Hebbar
Srinivas Hebbar
AMAvril Candida Mathias
Avril Candida Mathias

18 September 2024 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
PPPavithra Pradeep Prabhu
Pavithra Pradeep Prabhu
BMBarsha Mohanty
Barsha Mohanty
CLCynthia Lizzie Lobo
Cynthia Lizzie Lobo
SBSri Renukadevi Balusamy
Sri Renukadevi Balusamy
ASAmitha Shetty
Amitha Shetty
Priyanka SinghPriyanka Singh
Priyanka Singh
Breast cancer (BC) is a significant health challenge, ranking as the second leading cause of cancer-related death and the primary cause of mortality among women aged 45 to 55. Early detection is crucial for optimal prognosis. Among various treatment options available for cancer, chemotherapy remains the predominant approach. However, its patient-friendliness is hindered by cytotoxicity, adverse effects, multi-drug resistance, potential for recurrence, and high costs. This review explores extensively studied phytomolecules, elucidating their molecular mechanisms. It also emphasizes the importance of combination therapy, highlighting recent advancements in the exploration of diverse drug delivery systems and novel routes of administration. The regulatory considerations are crucial in translating these approaches into clinical practices. Consequently, there is growing interest in exploring the relationship between diet, cancer, and complementary and alternative medicine (CAM) in cancer chemotherapy. Phytochemicals like berberine, curcumin, quercetin, lycopene, sulforaphane, resveratrol, epigallocatechin gallate, apigenin, genistein, thymoquinone have emerged as promising candidates due to their pleiotropic actions on target cells through multiple mechanisms with minimal toxicity effects. This review focuses on extensively studied phytomolecules, elucidating their molecular mechanisms. It also emphasizes the importance of combination therapy, highlighting recent advancements in the exploration of diverse drug delivery systems and novel routes of administration. The regulatory considerations are crucial in translating these approaches into clinical practices. The present review provides a comprehensive understanding of the molecular mechanisms, coupled with well-designed clinical trials and adherence to regulatory guidelines, which pave the way for nutrition-based combination therapies to become a frontline approach in early-stage BC treatment.

17 April 2025 in Carbohydrate Polymers
Verified
Journal Article
Closed access
MMMahadev Manohar
Mahadev Manohar
ASAmitha Shetty
Amitha Shetty
CLCynthia Lizzie Lobo
Cynthia Lizzie Lobo
PJPraneetha Jain
Praneetha Jain
SHSrinivas Hebbar
Srinivas Hebbar
SESally A. El-Zahaby
Sally A. El-Zahaby

21 January 2025 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
MMManohar Mahadev
Manohar Mahadev
SBShruthi Ballal
Shruthi Ballal
ASAmitha Shetty
Amitha Shetty
Akhilesh DubeyAkhilesh Dubey
Akhilesh Dubey
SSShilpa S. Shetty
Shilpa S. Shetty
SESally A. El-Zahaby
Sally A. El-Zahaby

20 February 2024 in Heliyon
Verified
Journal Article
Open access
CLCynthia Lizzie Lobo
Cynthia Lizzie Lobo
MMManohar M
Manohar M
ASAmitha Shetty
Amitha Shetty
ASAnanya S
Ananya S
PKPallavi K
Pallavi K
Akhilesh DubeyAkhilesh Dubey
Akhilesh Dubey
Breast cancer treatment options are diverse, with tamoxifen commonly used as a selective estrogen receptor modulator (SERM) for hormone receptor-positive breast cancer. However, tamoxifen can have adverse systemic effects. Local transdermal therapy offers a potential solution by delivering the drug directly to the breast and minimizing systemic exposure. Hesperidin, a flavonoid, exerts synergistic effects when combined with anticancer agents. This combination therapy may be a more effective approach to breast cancer management. Analytical methods have been developed to quantify 4-Hydroxytamoxifen (4-HT) and hesperidin separately; however, no method currently exists for their simultaneous quantification in pharmaceutical formulations. This study aimed to develop and validate a reverse-phase high-performance liquid chromatography (RP-HPLC) method for the simultaneous quantification of 4-HT and hesperidin in liposomal formulations. A Design of Experiments (DoE) approach was employed using a Box-Behnken design (BBD) to optimize the RP-HPLC method. BBD allowed for a reduction in the number of required tests by creating a statistical model to estimate the significance of various factors and interactions. The methanol concentration, flow rate, and injection volume were considered as independent variables for optimization. A mobile phase (90:10 ratio of methanol: 0.1% v/v orthophosphoric acid) with a flow rate of 0.4 mL/min, and an injection volume of 10 μL was selected as optimized chromatographic condition. 4-HT showed a retention time (Rt) of 5.05 min and hesperidin showed an Rt of 7.11 min using an optimized analytical method and was detected at 275 nm. The developed RP-HPLC method was validated according to the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines, confirming its accuracy, precision, linearity, selectivity, and robustness. The validated method was then successfully applied to determine the entrapment efficiency and permeation of 4-HT and hesperidin into loaded liposomes. This study fills a gap in the literature by providing a simple and reliable RP-HPLC method for the simultaneous quantification of 4-HT and hesperidin in liposomal formulations.